Gebe kadınlarda parapnömonik efüzyonun yönetimi

Pnömoni ve parapnömonik efüzyon (PPE)'un görülme sıklığı gebe kadınlarda normal popülasyona kıyasla daha fazla değildir. Pnömoni gebe kadınlarda en sık ikinci infeksiyon olarak kabul edilir. PPE pnömoninin önemli bir komplikasyonudur ve özellikle tedavinin geciktiği veya antibiyotiğin uygun seçilmediği olgularda görülür. Gebe kadınlarda PPE yönetimi konusundaki veriler bir kaç olgu sunumu ile kısıtlıdır.

Management of parapneumonic effusion in pregnant women

Pneumonia and parapneumonic effusion (PPE) are not more common in pregnant women compared to normal population.Pneumonia is considered the second most common infection in pregnant women. PPE is a serious complication of pneumonia andoccurs especially in case of treatment delay or inappropriate antibiotic selection. The data on the management of PPE in pregnantwomen is limited to few case reports.

___

  • Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Curr Opin Infect Dis. 2018.
  • Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000;118:1158-71.
  • Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol 1989; 161:657-62.
  • Munn MB, Groome LJ, Atterbury JL, Baker SL, Hoff C. Pneumonia as a complication of pregnancy. J Matern Fetal Med 1999; 8:151-4.
  • Heffner, JE, McDonald, J, Barbieri, C, Klein J. Management of parapneumonic effusion. Arch Surg 1995;130:433-8.
  • Strange, C Sahn, SA. The clinician’s perspective on parapneumonic effusion and empyema. Chest.1993;103:259-261.
  • Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80.
  • Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005 ;33(10 Suppl):S390-7
  • Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW. Antibiotic levels in empyemic pleural fluid. Chest 2000;117(6):1734-9.
  • Liapakis IE, Light RW, Pitiakoudis MS, Karayiannakis AJ, Giamarellos-Bourboulis EJ, Ismailos G, et al. Penetration of clarithromycin in experimental pleural empyema model fluid. Respiration 2005;72:296-300.
  • FDA/CDER SBIA Chronicles. Drugs in Pregnancy and Lactation: Improved Benefit-Risk Information. January 22, 2015. Accessed July 25, 2016 at http://www.fda.gov/ downloads/Drugs/DevelopmentApprovalProcess/ SmallBusinessAssistance/UCM431132.pdf
  • Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract. 2001;55:658-60.
  • Ulutas H, Yekeler E, Ali Sak ZH, Doru I, Kuzucu A. Fibrinolytic therapy for parapneumonic empyema during pregnancy. Respiratory Medicine Case Reports. 2012;5:55-8.
  • Torbic H, Inaty H, Raja S, Choi H. Safe administration of intrapleural alteplase during pregnancy. J Thorac Dis 2017;9:E801-E804.
  • Sousa Gomes M, Guimarães M, Montenegro N. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med 2018;29:1-331.
  • Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Medicine 2011;9:107.
  • Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8
  • Oshodi T, Carlan SJ, Busowski M, Sand ME.Video assisted thoracic surgery in a second trimester pregnant woman with thoracic empyema: a case report. J Reprod Med 2015;60:172-4.
  • Kim JW, Kim JS, Cho JY, Lee DH. Successful video-assisted thoracoscopic lobectomy in a pregnant woman with lung cancer. Lung Cancer 2014;85:331-4.
Tüberküloz ve Toraks-Cover
  • ISSN: 0494-1373
  • Yayın Aralığı: 4
  • Başlangıç: 1951
  • Yayıncı: Tuba Yıldırım
Sayıdaki Diğer Makaleler

Difficulty in management of pneumothorax in an octogenarian with pulmonary fibrosis

Hiroaki SATOH, Hajime OSAWA, Shinichiro OKAUCHİ

Pulmoner rehabilitasyon programını tamamlayan koah tanılı olgularda oral nütrisyonel destek; altı ay ve bir yıllık takipleri

Pınar ERGÜN, Fatma ŞENGÜL, Dicle KAYMAZ, Nurcan EGESEL, Filiz TAŞDEMİR, İpek CANDEMİR

Obez olan ve olmayan osas’lı olgularda nötrofil lenfosit oranının önemi var mı?

Nursel DİKMEN, Nagihan BİLAL, Fulsen BOZKUŞ, Hüseyin ARPAĞ, Anıl SAMUR, Nurhan ATİLLA

Gebelikte yabancı cisim aspirasyonu: Başarıyla çıkarılan leblebi tanesi

Barış Mustafa POYRAZ, Ayşegül ALKILIÇ, Numan NUMANOĞLU, Servet Seçkin Tunç KASAP, Gökhan TULUNAY, Murat ÖZKAN

Nemlendirme tedavisi; KOAH ve OUAS hastalarında uzun vadeli etkileri

Sevinç SARINÇ ULAŞLI, Antonio ESQUINAS, Dorina ESENDAĞLI

Immuno-checkpoint inhibitor-associated hyper-eosinophilia and tumor shrinkage

Hiroaki SATOH, Shijima TAGUCHI, Hajime OSAWA, Katsunori KAGOHASHI, Shinichiro OKAUCHI

Look closer to welders’ lung

Emine AKSOY, İpek ÖZMEN, Tülay TÖRÜN, Haluk ÇALIŞIR, Reyhan YILDIZ, Peri ARBAK, Hamza OGUN, Elif YILDIRIM

Allerjik rinitli hastaların sigaraya yönelik tutumları astım ve koah hastalarından farklı mı?

Ömür AYDIN, Fatma ÇİFTÇİ, Dilşad MUNGAN, Gülfem ÇELİK, Elif ŞEN, Zeynep ÇELEBİ SÖZENER, Şadan SOYYİĞİT

Pakistan, Hazara Bölgesinde akciğer tüberkülozu hastalarının birinci basamak tedavilerinde Mycobacterium tuberculosis ilaç direnci paterni

Hafiz Sajid AKBAR, Faheem JAN, Sadia S., Waqas AHMAD, Manzoor AHMAD, Anwar KHALID, Muhammad Taj AKBAR, Shahid WALI

Pakistan’da çok ilaca dirençli tüberküloz için toplum temelli tedavi alan hastalarda advers etki gelişimi

Arshad JAVAID, Faheem JAN, Mazhar Ali KHA, Mifra RAUF, Mir Azam KHA, Anila BASİT, Sumaira MEHREEN